Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma

Almost 75% of renal cancers are renal clear cell carcinomas (KIRC). Accumulative evidence indicates that epigenetic dysregulations are closely related to the development of KIRC. Cancer immunotherapy is an effective treatment for cancers. The aim of this study was to identify immune-related differen...

Full description

Bibliographic Details
Main Authors: Zhi-Yong Yao, Chaoqung Xing, Yuan-Wu Liu, Xiao-Liang Xing
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.750997/full
_version_ 1818742180540317696
author Zhi-Yong Yao
Zhi-Yong Yao
Chaoqung Xing
Yuan-Wu Liu
Xiao-Liang Xing
Xiao-Liang Xing
author_facet Zhi-Yong Yao
Zhi-Yong Yao
Chaoqung Xing
Yuan-Wu Liu
Xiao-Liang Xing
Xiao-Liang Xing
author_sort Zhi-Yong Yao
collection DOAJ
description Almost 75% of renal cancers are renal clear cell carcinomas (KIRC). Accumulative evidence indicates that epigenetic dysregulations are closely related to the development of KIRC. Cancer immunotherapy is an effective treatment for cancers. The aim of this study was to identify immune-related differentially expressed genes (IR-DEGs) associated with aberrant methylations and construct a risk assessment model using these IR-DEGs to predict the prognosis of KIRC. Two IR-DEGs (SLC11A1 and TNFSF14) were identified by differential expression, correlation analysis, and Cox regression analysis, and risk assessment models were established. The area under the receiver operating characteristic (ROC) curve (AUC) was 0.6907. In addition, we found that risk scores were significantly associated with 31 immune cells and factors. Our present study not only shows that two IR-DEGs can be used as prognosis signatures for KIRC, but also provides a strategy for the screening of suitable prognosis signatures associated with aberrant methylation in other cancers.
first_indexed 2024-12-18T02:08:25Z
format Article
id doaj.art-a00eef66941149b9b143a98a63c7ce25
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-18T02:08:25Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-a00eef66941149b9b143a98a63c7ce252022-12-21T21:24:33ZengFrontiers Media S.A.Frontiers in Genetics1664-80212021-12-011210.3389/fgene.2021.750997750997Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell CarcinomaZhi-Yong Yao0Zhi-Yong Yao1Chaoqung Xing2Yuan-Wu Liu3Xiao-Liang Xing4Xiao-Liang Xing5School of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua, ChinaThe First Affiliated Hospital of Hunan University of Medicine, Huaihua, ChinaSchool of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua, ChinaBeijing Advanced Innovation Center for Food Nutrition and Human Health, China Agricultural University, Beijing, ChinaSchool of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua, ChinaThe First Affiliated Hospital of Hunan University of Medicine, Huaihua, ChinaAlmost 75% of renal cancers are renal clear cell carcinomas (KIRC). Accumulative evidence indicates that epigenetic dysregulations are closely related to the development of KIRC. Cancer immunotherapy is an effective treatment for cancers. The aim of this study was to identify immune-related differentially expressed genes (IR-DEGs) associated with aberrant methylations and construct a risk assessment model using these IR-DEGs to predict the prognosis of KIRC. Two IR-DEGs (SLC11A1 and TNFSF14) were identified by differential expression, correlation analysis, and Cox regression analysis, and risk assessment models were established. The area under the receiver operating characteristic (ROC) curve (AUC) was 0.6907. In addition, we found that risk scores were significantly associated with 31 immune cells and factors. Our present study not only shows that two IR-DEGs can be used as prognosis signatures for KIRC, but also provides a strategy for the screening of suitable prognosis signatures associated with aberrant methylation in other cancers.https://www.frontiersin.org/articles/10.3389/fgene.2021.750997/fullKIRCDEGsDMPSimmune-relatedprognosis
spellingShingle Zhi-Yong Yao
Zhi-Yong Yao
Chaoqung Xing
Yuan-Wu Liu
Xiao-Liang Xing
Xiao-Liang Xing
Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
Frontiers in Genetics
KIRC
DEGs
DMPS
immune-related
prognosis
title Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
title_full Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
title_fullStr Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
title_full_unstemmed Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
title_short Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
title_sort identification of two immune related genes correlated with aberrant methylations as prognosis signatures for renal clear cell carcinoma
topic KIRC
DEGs
DMPS
immune-related
prognosis
url https://www.frontiersin.org/articles/10.3389/fgene.2021.750997/full
work_keys_str_mv AT zhiyongyao identificationoftwoimmunerelatedgenescorrelatedwithaberrantmethylationsasprognosissignaturesforrenalclearcellcarcinoma
AT zhiyongyao identificationoftwoimmunerelatedgenescorrelatedwithaberrantmethylationsasprognosissignaturesforrenalclearcellcarcinoma
AT chaoqungxing identificationoftwoimmunerelatedgenescorrelatedwithaberrantmethylationsasprognosissignaturesforrenalclearcellcarcinoma
AT yuanwuliu identificationoftwoimmunerelatedgenescorrelatedwithaberrantmethylationsasprognosissignaturesforrenalclearcellcarcinoma
AT xiaoliangxing identificationoftwoimmunerelatedgenescorrelatedwithaberrantmethylationsasprognosissignaturesforrenalclearcellcarcinoma
AT xiaoliangxing identificationoftwoimmunerelatedgenescorrelatedwithaberrantmethylationsasprognosissignaturesforrenalclearcellcarcinoma